Diabetes and Vascular Disease: Basic Concepts of Nitric Oxide Physiology, Endothelial Dysfunction, Oxidative Stress and Therapeutic Possibilities
Journal:
Current Vascular Pharmacology
Volume:
8
Page:
526-544
Author(s):
Verena K. Capellini, Andrea C. Celotto, Caroline F. Baldo, Vania C. Olivon, Fernanda Viaro, Alfredo J. Rodrigues and Paulo R.B. Evora
Animal Models for Studying Neointima Formation
Journal:
Current Vascular Pharmacology
Volume:
8
Page:
198-219
Author(s):
Jamie Y. Jeremy and Anita C. Thomas
Advanced Diabetes Care: Three Levels of Prediction, Prevention & Personalized Treatment
Journal:
Current Diabetes Reviews
Volume:
6
Page:
42-51
Author(s):
Olga Golubnitschaja
Aldose Reductase Inhibition: Emerging Drug Target for the Treatment of Cardiovascular Complications
Journal:
Recent Patents on Cardiovascular Drug Discovery
Volume:
5
Page:
25-32
Author(s):
Aramati B.M. Reddy and Kota V. Ramana
A Concept of Homeostatic Inflammation Provided by Endogenous TLR4 Agonists that Function Before and After Danger Signal for Metastasis
Journal:
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume:
8
Page:
337-347
Author(s):
Yoshiro Maru
Relevance of Dyslipidaemia and its Consequences in Periodontal Patients with Co-Existing Cardiovascular Disease and Diabetes Mellitus: Therapeutic Targets
Journal:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume:
3
Page:
214-224
Author(s):
Mena Soory
Irbesartan and Hydrochlorothiazide Association in the Treatment of Hypertension
Journal:
Current Vascular Pharmacology
Volume:
7
Page:
120-136
Author(s):
Giuseppe Derosa, Ilaria Ferrari and Arrigo F.G. Cicero
State of the Art Clinical Efficacy and Safety Evaluation of N-Acetylcarnosine Dipeptide Ophthalmic Prodrug. Principles for the Delivery, Self-Bioactivation, Molecular Targets and Interaction with a Highly Evolved Histidyl-Hydrazide Structure in the Treatment and Therapeutic Management of a Group of Sight-Threatening Eye Diseases
Journal:
Current Clinical Pharmacology
Volume:
4
Page:
4-37
Author(s):
Mark A. Babizhayev and Anne Kasus-Jacobi
Resistance to Aspirin and Thienopyridines in Diabetes Mellitus and Metabolic Syndrome
Journal:
Current Vascular Pharmacology
Volume:
6
Page:
313-328
Author(s):
Giovanni Anfossi, Isabella Russo and Mariella Trovati
Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 (LOX-1), a Relevant Target for Diabetic Vasculopathy?
Journal:
Cardiovascular & Hematological Disorders-Drug Targets
Volume:
8
Page:
203-211
Author(s):
Genevieve Renier